ProCE Banner Activity

First-line Therapy Selection in HER2+ mBC: Clinical/Nonclinical Factors and New Data

Slideset

Download these slides from a webinar covering key clinical and nonclinical factors in the selection of first-line therapy in patients with HER2-positive metastatic breast cancer, including expert’s review of the latest clinical data informing the standard of care.

Released: May 13, 2025

Expiration: November 12, 2025

Share

Provided by

Provided by Clinical Care Options, LLC. in partnership with Smart Patients.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Smart Patients

ProCE Banner